, Tracking Stock Market Picks
Enter Symbol:
Infinity Pharmaceuticals, Inc. (INFI) [hlAlert]

Positive INFI
up 112.58 %

Infinity Pharmaceuticals, Inc. (INFI) upgraded to Positive by Susquehanna Financial

Posted on: Friday,  Oct 31, 2008  9:25 AM ET by Susquehanna Financial

Susquehanna Financial rated Positive Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) on 10/31/2008, when the stock price was $4.29. Since
then, Infinity Pharmaceuticals, Inc. has gained 112.59% as of 01/25/2016's recent price of $9.12.
If you would have followed this Susquehanna Financial's recommendation on INFI, you would have gained 112.58% of your investment in 2642 days.

Infinity Pharmaceuticals, Inc. (IPI) has developed a pipeline of product candidates for multiple cancer indications. The Company?s lead product candidate, retaspimycin hydrochloride (IPI-504) is an intravenously-administered small molecule inhibitor of heat shock protein 90 (Hsp90). Hsp90 is a central component of the cellular chaperone system, which supports and stabilizes cancer-causing proteins, such as c-Kit, EGFR, and HER2, enabling multiple forms of cancer to thrive. Inhibition of the Hsp90 chaperone knocks out this critical source of support for cancer cells, leading to tumor growth inhibition and cancer cell death. In October 2008, the commenced an international Phase III registration study of IPI-504 in patients with refractory gastrointestinal stromal tumors (GIST), based on the activity and safety data from a Phase I trial reported during the year ended December 31, 2008.

Since its inception in 1987, the Susquehanna International Group of Companies (SIG)* has grown from a trading firm on the Philadelphia Stock Exchange to one of the largest privately held financial institutions in the world. With more than 1,500 employees worldwide, SIG sits at the helm of the latest trends and developments in trading and market making, institutional sales, research, private equity, venture capital, and investment banking. SIG has offices across North America, Europe, Asia, and Australia. SIG distinguishes itself through its global market presence, capital commitment, and its grasp of trading dynamics. It excels at decision theory and implementing sophisticated pricing probability models.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/31/2008 9:25 AM Buy
as of 12/24/2008
1 Week up  2.40 %
1 Month down  -25.46 %
3 Months down  -71.58 %
1 YTD down  -25.28 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/7/2007 9:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy